The presence of isolated anticytoplasmic antibodies in ANA-negative patients with autoimmune diseases indicates that the term ACA is more appropriate than ANA for diagnosing and reporting SARDs, as it may help reduce false-negative results. Here, BTG3 is linked to autoimmune disease.